Jefferies upgrades Zydus Life to ‘Buy’ on strong US pipeline potential, stock up 4%

August 28, 2024

Global brokerage firm Jefferies has upgraded Zydus Lifesciences to a ‘Buy’ rating, citing the strength of the company’s US pipeline as a major growth driver. Jefferies raised its target price to Rs 1,450 from Rs 1,210, indicating a 30% upside from the previous closing price of Rs 1,113.80.

More To Explore

F&O Talk| Nifty eyes further gains after crossing 25k mark: Is 25,600 the next target? Sudeep Shah weighs in

The Indian stock market rebounded strongly this week. Nifty 50 crossed 25,000, recovering previous losses. Operation Sindoor boosted market sentiment. Midcap and Smallcap indices also

May 17, 2025

Arvind Fashions reports Rs 17 crore Q4 Loss despite 13.7% YoY revenue growth

Arvind Fashion Ltd faced a significant standalone net loss of Rs17 crore in Q4, a 192% yoy decline, despite a 13.7% revenue increase to Rs150

May 17, 2025

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003